AKT1 and B-cell chronic lymphocytic leukemia: Sustained BCR-signaling that prolong ERK1/2 and AKT(PKB) signaling, increases the expression of the antiapoptotic protein myeloid cell leukemia-1 (Mcl-1), promoting cell survival in CLL (Petlickovski et al., 2005).